4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels-Reference-Cited by-同舟云学术

4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels

Published:2019-12-11 Issue:3 Volume:237 Page:757-772
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Abiero Arvie,Botanas Chrislean Jun,Custodio Raly James,Sayson Leandro Val,Kim Mikyung,Lee Hyun Jun,Kim Hee Jin,Lee Kun Won,Jeong Youngdo,Seo Joung-Wook,Ryu In Soo,Lee Yong Sup,Cheong Jae Hoon

Funder

Ministry of Food and Drug Safety

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-019-05412-y.pdf

Reference64 articles.

1. Barker JM, Taylor JR, De Vries TJ, Peters J (2015) Brain-derived neurotrophic factor and addiction: pathological versus therapeutic effects on drug seeking. Brain Res 1628:68–81

2. Barrot M, Olivier JD, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ, Impey S, Storm DR, Neve RL, Yin JC, Zachariou V, Zachariou V (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci 99(17):11435–11440

3. Baumeister D, Tojo LM, Tracy DK (2015) Legal highs: staying on top of the flood of novel psychoactive substances. Ther Adv Psychopharmacol 5(2):97–132